Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > David Happel > Profile

David Happel

Affiliations

  • President & Ceo at Sagimet Biosciences Inc. (SGMT), 2025-02-07
  • Evp, Commercial Dev & Strategy at Horizon Pharma Plc (HZNP), 2017-10-26
  • Chief Commercial Officer at Raptor Pharmaceutical Corp (RPTP), 2016-10-26
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
SGMT $5.27 12,100 $63,730.70 639,200 2024-03-26 Filing
SGMT $4.10 1,600 $6,560.00 627,100 2023-12-07 Filing
SGMT $2.35 590 $1,386.50 590 2023-11-16 Filing